Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Diagnostic Performance of Artificial Intelligence in Detection of Renal Cell Carcinoma: A Systematic Review and Meta-Analysis Publisher Pubmed



Gouravani M1 ; Shahrabi Farahani M2 ; Salehi MA3 ; Shojaei S3 ; Mirakhori S4 ; Harandi H3 ; Mohammadi S5 ; Saleh RR6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Musculoskeletal Imaging Research Center (MIRC), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Medical Students Research Committee, Shahed University, Tehran, Iran
  3. 3. School of Medicine, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran
  4. 4. Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Mallinckrodt Institute of Radiology, Washington University in St. Louis, Saint Louis, United States
  6. 6. Department of Oncology, McGill University, Montreal, H3A 0G4, QC, Canada
  7. 7. Division of Medical Oncology, McGill University Health Centre, Montreal, H4A 3J1, QC, Canada

Source: BMC Cancer Published:2025


Abstract

Objectives: The detection of renal cell carcinoma (RCC) tumors in the earlier stages is of great importance for more effective treatment. Encouraged by the key role of imaging in the management of RCC, we conducted a systematic review and meta-analysis of the studies that made use of artificial intelligence (AI) for the detection of RCC to quantitatively determine the performance of AI for distinguishing related renal lesions. Materials and methods: PubMed, Scopus, CENTRAL, and Embase electronic databases were systematically searched in November 2024 to identify studies that applied AI for the detection or classification of RCC. We conducted a meta-analysis to evaluate the diagnostic performance of utilized algorithms. Moreover, meta-regression was conducted over suspected covariates to evaluate potential sources of inter-study heterogeneity. Publication bias and quality assessment were also done for the included studies. Results: Sixty-four studies were included in this systematic review, of which 31 studies were selected for meta-analysis. The studies assessing algorithms’ performance on internal validation showed pooled sensitivity and specificity of 85% (95% confidence interval [CI], 82 to 87) and 76% (95% CI, 70 to 80), respectively. Moreover, externally validated Al algorithms had a pooled sensitivity and specificity of 80% (95% CI, 73 to 84) and 90% (95% CI, 84 to 93), respectively. Studies that performed internal validation for clinician performance had a pooled sensitivity of 79% (95% CI, 72 to 85) and specificity of 60% (95% CI, 49 to 70). Conclusion: The findings of the present study validate the acceptable performance of AI algorithms when contrasted with medical professionals in the identification and categorization of RCC. Nevertheless, the presence of heterogeneity between studies and the absence of coherence in the results underscore the necessity for the cautious interpretation of these results and additional prospective studies. © The Author(s) 2025.
Experts (# of related papers)